BackTitan Medical Overview

Titan Medical Profit Margin

Titan Medical (TMDI) has a profit margin of -531.26%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Jun 2024

Annual Profit Margin (TTM)

-531.26%
↓ 651.38% YoY

Trailing 12 months ending Jun 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Titan Medical (TMDI) FAQ

The latest profit margin for TMDI is -531.26% as of June 2024. That compares with -70.7% in the prior-year period — down 651.4% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Titan Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, TMDI's profit margin moved from -70.7% to -531.26% — a 651.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Titan Medical's valuation or profitability profile.

Against Healthcare companies, TMDI currently prints -531.26% for profit margin, while the sector average sits near 17.63%. That is roughly 3113.7% below the sector mean. Large gaps often invite a closer look at Titan Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Titan Medical converts resources into returns. At -531.26%, TMDI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -70.7% in the prior-year period — down 651.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TMDI's profit margin (-531.26%), review year-over-year change from -70.7%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.